Rolf Erttmann
Impact in
- Hematology top 5%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
- Transplantation top 10%
- Renal Transplantation Outcomes and Treatments
Papers in
- Hematology 12
- Hematopoietic Stem Cell Transplantation 11
- Acute Myeloid Leukemia Research 4
- Autoimmune and Inflammatory Disorders Research 2
- Oncology 7
- Neutropenia and Cancer Infections 4
- Polyomavirus and related diseases 3
- Co-authors
- William Krüger (10 shared papers)Nicolaus Martin Kröger (8 shared papers)H. Kabisch (11 shared papers)Udo F. W. Bode (1 shared paper)Dietrich von Schweinitz (1 shared paper)Peter Weinel (1 shared paper)D. J. Byrd (1 shared paper)Dietrich Bürger (1 shared paper)
In The Last Decade
Rolf Erttmann
16 papers receiving 364 citations
Peers
Comparison fields: 5 of 39
- Hematology 198
- Transplantation 30
- Hepatology 71
- Oncology 95
- Genetics 29
Countries citing papers authored by Rolf Erttmann
This map shows the geographic impact of Rolf Erttmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rolf Erttmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rolf Erttmann more than expected).
Fields of papers citing papers by Rolf Erttmann
This network shows the impact of papers produced by Rolf Erttmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rolf Erttmann. The network helps show where Rolf Erttmann may publish in the future.
Co-authors
The 25 scholars most cited alongside Rolf Erttmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 124 | |
| 2 | 1999 | 45 | |
| 3 | 2001 | 41 | |
| 4 | 1998 | 34 | |
| 5 | 2009 | 31 | |
| 6 | High dose chemotherapy with busulfan, cyclophosphamide, and etoposide as conditioning regimen for allogeneic bone marrow transplantation for patients with acute myeloid leukemia in first complete remission. | 1997 | 30 |
| 7 | 2000 | 23 | |
| 8 | 2008 | 21 | |
| 9 | Use of cryopreserved bone marrow in unrelated allogeneic transplantation. | 1996 | 19 |
| 10 | 1996 | 9 | |
| 11 | 1997 | 7 | |
| 12 | 1999 | 3 | |
| 13 | Factors influencing the haematological recovery after allogeneic bone marrow transplantation in leukaemia patients treated with methotrexate-containing GVHD prophylaxis: a single-centre experience. | 1997 | 2 |
| 14 | 1981 | 1 | |
| 15 | 2002 | 1 | |
| 16 | 2003 | 1 | |
| 17 | 1983 | 0 |
About Rolf Erttmann
Rolf Erttmann is a scholar working on Hematology, Oncology, Pediatrics, Perinatology and Child Health, Hepatology and Emergency Medicine, having authored 17 papers that have together received 392 indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (11 papers), Acute Myeloid Leukemia Research (4 papers), Neutropenia and Cancer Infections (4 papers), Childhood Cancer Survivors' Quality of Life (4 papers), Acute Lymphoblastic Leukemia research (3 papers), Polyomavirus and related diseases (3 papers), Autoimmune and Inflammatory Disorders Research (2 papers) and Hematological disorders and diagnostics (2 papers). The work is most often cited by research in Hematology (198 citations), Transplantation (30 citations), Hepatology (71 citations), Oncology (95 citations) and Genetics (29 citations). Rolf Erttmann has collaborated with scholars based in Germany and Russia. Frequent co-authors include William Krüger, Nicolaus Martin Kröger, H. Kabisch, Udo F. W. Bode, Dietrich von Schweinitz, Peter Weinel, D. J. Byrd, Dietrich Bürger, D. Harms and Hartmut Hecker. Their work appears in journals such as Bone Marrow Transplantation, Supportive Care in Cancer, Transplantation and Cellular Therapy, European Journal of Cancer and Annals of Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.